FDA Inspection 1012063 — Hiralal Maheshwari, MD

Hiralal Maheshwari, MD — FEI 3013134992

The FDA completed an inspection of Hiralal Maheshwari, MD on May 16, 2017 in Crystal Lake, IL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
May 16, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Crystal Lake, IL (United States)

Additional details

Clinical Investigator (CI)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.